SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-214184
Filing Date
2013-05-10
Accepted
2013-05-10 16:13:08
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d510101d10q.htm 10-Q 291002
2 EX-10.1 d510101dex101.htm EX-10.1 32234
3 EX-31.1 d510101dex311.htm EX-31.1 6068
4 EX-31.2 d510101dex312.htm EX-31.2 6037
5 EX-32 d510101dex32.htm EX-32 4439
  Complete submission text file 0001193125-13-214184.txt   1820607

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bgmd-20130331.xml EX-101.INS 134155
7 XBRL TAXONOMY EXTENSION SCHEMA bgmd-20130331.xsd EX-101.SCH 23869
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bgmd-20130331_cal.xml EX-101.CAL 36993
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bgmd-20130331_def.xml EX-101.DEF 122284
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bgmd-20130331_lab.xml EX-101.LAB 184246
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bgmd-20130331_pre.xml EX-101.PRE 141665
Mailing Address 610N LINCOLN STREET WALTHAM MA 02451
Business Address 610N LINCOLN STREET WALTHAM MA 02451 781-890-1199
BG Medicine, Inc. (Filer) CIK: 0001407038 (see all company filings)

IRS No.: 043506204 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33827 | Film No.: 13833598
SIC: 2835 In Vitro & In Vivo Diagnostic Substances